Specialisation
Retina and Vitreous.
Full title
Phase III, multicentre, randomised, double-blind, sham-controlled trial to assess the efficacy and safety of lampalizumab administered by intravitreal injection to patients with geographic atrophy secondary to age-related macular degeneration.
Promoter
Roche Pharma.
Start date
September 2014
End date
June 2018
Researchers
Main: Dr Rafael Navarro.
